Explore BPC-157/KPV/GHK-Cu dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator data.
This is a compounded research blend of three repair and anti-inflammatory peptides — BPC-157, KPV, and GHK-Cu — sold for tissue-repair research. No human trial of the combination exists; it ships as a lyophilized powder, so the key checks are whether all three peptides are present and in the stated amounts.
See the standalone entries for BPC-157, KPV, and GHK-Cu for full mechanism. In brief: BPC-157 — proposed nitric-oxide-system modulation, vascular endothelial growth factor receptor 2 (VEGFR2) signalling, and pentadecapeptide-specific effects on tendon, ligament, and gut epithelial repair in rodent models. KPV — anti-inflammatory tripeptide that suppresses NF-κB activation in epithelial and immune cells, with pre-clinical activity in colitis models. GHK-Cu — copper-binding peptide implicated in wound healing, dermal collagen synthesis, and modulation of stem-cell gene expression.
No regulatory approvals for the blend or for any of its three components. Each individual component is described in its standalone entry in this catalogue. **Typical dose:** No validated human dose for the blend. Vendor-typical compounded ratios pair BPC-157 250–500 µg, KPV 250–500 µg, and GHK-Cu 1–2 mg per dose, given subcutaneously, but these are commercial conventions and not the output of any registered dose-finding study.
Compounded research-peptide blend. No published human trial of the combination; each individual component has its own (limited) pre-clinical literature.
BPC-157/KPV/GHK-Cu has a reported half-life of ~4 hours (BPC-157-driven). The pharmacokinetic reference models an interval of once daily; this is not a measured community cadence or a dosing recommendation. All three components are short-acting and clear within hours, so there is little buildup. Consistent daily (or split) dosing keeps the combined effect steady. Pharmacokinetic source: Pre-clinical estimates for each component (BPC-157, KPV, GHK-Cu). BPC-157/KPV/GHK-Cu is a blend of BPC-157 and GHK-Cu and KPV, so a reconstitution figure for it covers the combined vial contents rather than any single component. It is catalogued under Other Peptides on WPA.
4 BPC-157/KPV/GHK-Cu reconstitution calculations have been logged by the WPA community.
This is the lifetime header population. Each chart and its associated analysis below use their own selected period and denominator; frequency responses are a separate cohort.
These figures come from anonymized WPA peptide calculator sessions, not verified administrations or unique people. Separate modal inputs do not establish a joint protocol. They are community input statistics — not dosing recommendations, and not medical advice.
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.